<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01607996</url>
  </required_header>
  <id_info>
    <org_study_id>HUG 02-0555</org_study_id>
    <nct_id>NCT01607996</nct_id>
  </id_info>
  <brief_title>Effect of Epidural Anesthesia on Pancreatic Perfusion and Clinical Outcome in Patients With Severe Acute Pancreatitis</brief_title>
  <official_title>Phase 1 Study of Epidural Anesthesia on Pancreatic Perfusion and Clinical Outcome in Patients With Severe Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the safety, the potential beneficial effect of epidural
      anesthesia on pancreatic perfusion and clinical outcome of patients with severe acute
      pancreatitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High mortality in severe acute pancreatitis (AP) is linked to necrosis of the gland. Animal
      studies showed that epidural anesthesia (EA) restores pancreatic microcirculation and
      decreases the severity of AP. The aim of the study is to evaluate the safety of EA, its
      effect on pancreatic perfusion and clinical outcome of patients with AP.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with adverse events related to epidural anesthesia</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 to 5 weeks</time_frame>
    <description>Adverse events related to epidural anesthesia include hypotensive episodes or infection of the catheter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pancreatic perfusion measured by computerized tomography</measure>
    <time_frame>On day 0 and day 2 or 3 after hospital admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 to 5 weeks</time_frame>
    <description>Lenght of stay, admission to intensive care unit, need for surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Severe Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Patient controlled intravenous analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl (10 microg/ml) continuous intravenous infusion at a rate of 10 to 20 microg/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carbostesin (0.1%) and Fentanyl (2 microg/ml) at a continuous flow of 6 to 15 ml/hour</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural anesthesia</intervention_name>
    <description>Epidural will be performed using carbostesin (0.1%), fentanyl (2 microg/ml) administered continuously at a rate of 6 to 15 ml/hour</description>
    <arm_group_label>Epidural anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Patient controlled intravenous analgesia</intervention_name>
    <description>Fentanyl 10 microg/ml at continuous flow of 10 to 20 microg/hour</description>
    <arm_group_label>Patient controlled intravenous analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute pancreatitis with Ranson Criteria over 2, and/or CRP over 100, and or pancreatic
             necrosis on CT scan

        Exclusion Criteria:

          -  Coagulation disorders

          -  Skin infection of the vertebral region
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Demirag A, Pastor CM, Morel P, Jean-Christophe C, Sielenkämper AW, Güvener N, Mai G, Berney T, Frossard JL, Bühler LH. Epidural anaesthesia restores pancreatic microcirculation and decreases the severity of acute pancreatitis. World J Gastroenterol. 2006 Feb 14;12(6):915-20.</citation>
    <PMID>16521220</PMID>
  </reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2012</study_first_submitted>
  <study_first_submitted_qc>May 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>May 25, 2012</last_update_submitted>
  <last_update_submitted_qc>May 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Leo Buhler</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Epidural anesthesia</keyword>
  <keyword>pancreatic perfusion</keyword>
  <keyword>pancreatic necrosectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

